-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ODpAVA6DWFz+YYjM4wtqL+bjAcwBJcEZpKTaN3pPslw3FGQ5izbpvfn+pt1UQxta BBTPxjeC4yowaUO0L9dYWw== 0000950136-06-006435.txt : 20060808 0000950136-06-006435.hdr.sgml : 20060808 20060808101430 ACCESSION NUMBER: 0000950136-06-006435 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20060808 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20060808 DATE AS OF CHANGE: 20060808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALLIED HEALTHCARE INTERNATIONAL INC CENTRAL INDEX KEY: 0000890634 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 133098275 STATE OF INCORPORATION: NY FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11570 FILM NUMBER: 061011319 BUSINESS ADDRESS: STREET 1: 555 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2127500064 MAIL ADDRESS: STREET 1: 555 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: TRANSWORLD HEALTHCARE INC DATE OF NAME CHANGE: 19970610 FORMER COMPANY: FORMER CONFORMED NAME: TRANSWORLD HOME HEALTHCARE INC DATE OF NAME CHANGE: 19940728 8-K 1 file1.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): August 8, 2006 (August 8, 2006)

ALLIED HEALTHCARE INTERNATIONAL INC.
(Exact Name of Registrant as Specified on its Charter)


                1-11570                                         13-3098275                        
(Commission File Number) (IRS Employer Identification Number)

                                                New York                                                
(State or Other Jurisdiction of Incorporation or Organization)

555 Madison Avenue, New York, New York 10022
(Address of Principal Executive Offices)

                                        (212) 750-0064                                        
(Registrant’s Telephone Number, Including Area Code)

                                                                                                                            
(Former Name or Former Address, If Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provision:

           Written communications pursuant to Rule 425 under the Securities Act.
           Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.



ITEM 2.02.    RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On August 8, 2006, Allied Healthcare International Inc. issued a press release announcing its earnings for the quarter ended June 30, 2006. A copy of the press release is attached to this Form 8-K.

ITEM 9.01    FINANCIAL STATEMENTS AND EXHIBITS.


(d
)
Exhibits.

99.1    Press release, dated August 8, 2006, of Allied Healthcare International Inc.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 8, 2006


  ALLIED HEALTHCARE INTERNATIONAL INC.
  By: /s/ Marvet Abbassi                        
    Name:   Marvet Abbassi
    Title:   Financial Controller



EX-99.1 2 file2.htm EXHIBIT 99.1

Exhibit 99.1

ALLIED HEALTHCARE INTERNATIONAL INC.
REPORTS FISCAL 2006 THIRD QUARTER RESULTS


  Fiscal 2006 Fiscal 2005
  Third quarter Third quarter
Revenue ($m) 73.2 89.5
Gross Profit ($m) 22.2 26.2
Gross Margin % 30.3% 29.3%
Diluted EPS ($) 0.03 0.10

NEW YORK, NY — August 8, 2006 — Allied Healthcare International Inc. (Nasdaq: AHCI; AIM: AHI), a leading provider of flexible healthcare staffing services in the United Kingdom, has reported the results of its fiscal 2006 third quarter ended June 30, 2006.

Allied’s revenue in the third quarter of 2006 was $73.2 million, a decrease of 18.2% from the same period in 2005. Gross profit decreased by 15.4% to $22.2 million in this quarter, compared to $26.2 million in the comparable period last year. Gross profit margin this quarter increased to 30.3% from 29.3% during the same period last year.

Net income for the quarter ended June 30, 2006 was $1.4 million, or $0.03 per diluted share, compared with net income of $4.7 million, or $0.10 per diluted share, during the comparable period in fiscal 2005.

Allied’s core Social Services business continued to expand again during the third quarter, growing more than 5% from the previous quarter. The expansion of the Social Services sector continued to be primarily attributable to a greater demand from the elderly population and increased contracting activity with local governments.

In the previous quarter it was reported that Allied’s National Health Services (NHS) revenue had declined 36% for the year to date. The decline continued during the third quarter, resulting in a 48% total decline in NHS revenue for the year to date. As a result, the Company’s gross profit mix is currently as follows: NHS 13% (previous quarter 16%); Nursing Homes 15% (previous quarter 16%); Social Services, including private clients, 69% (previous quarter 64%); and Oxygen 4% (previous quarter 4%). The reduction in NHS business was again driven by a decrease in expenditures and the NHS’s downward price pressure on the cost of agency nurses.

Allied will continue to emphasize the Social Services sector and expand its long-term care services. This favorable flexible staffing mix is reflected in Allied’s 30.3% gross margin for the quarter, verses 29.3% for the third quarter last year.

Timothy Aitken, Allied Chairman and Chief Executive Officer, commented: ‘‘Although we continue to face challenges in the NHS sector and our Oxygen respiratory business, these challenges are being addressed and, meanwhile, Allied’s existing network of branches has continued to provide more social-care and home-care visits, as reflected in our expanding gross margins.’’

On February 1, 2006, Allied began delivering at-home respiratory therapy to patients through its new five-year Oxygen contract. The transition from delivering to pharmacists to directly supplying patients has taken longer than anticipated, resulting in higher costs as the Company works to service both home patients and the pharmacy trade for the interim period. Allied anticipates these costs continuing into the next fiscal year, though the Company is considering alternatives for improving operational efficiencies in this business. A recent internal survey of 233 patients indicated that they are happy with




the service, and Allied is working closely with the Department of Health to convert the remaining pharmacy-based customers as quickly as possible.

Allied is focused on reducing Selling, General and Administrative costs, which represented approximately 26.4% of gross revenues in the third quarter, compared with 24.6% of gross revenues in the second quarter and 20.4% during the same period the year before. A $1 Million increase in expenses from the same period the previous year was attributable to higher depreciation of $0.5 million for the new Information Technology system and $1.1 million in additional costs from the Company’s respiratory-distribution business. Excluding these costs, Allied has demonstrated progress in reducing the ongoing costs associated with its core division.

Allied invites all those interested in hearing management’s discussion of the second-quarter results to join the conference call by dialing 877-407-9205 on Tuesday, Aug. 8, 2006, at 12:00 PM EST. International participants may access the call by dialing 201-689-8054. A replay will be available for one week following the day of the call by dialing 877-660-6853 for domestic participants and 201-612-7415 for international participants. When prompted, refer to replay passcode account number 286 and conference ID number 210878. Participants may also access a live Web cast of the conference call through the ‘‘Investors’’ section of the Allied website at www.alliedhealthcare.com. The presentation will be available and archived for 90 days.

ABOUT ALLIED HEALTHCARE INTERNATIONAL INC.

Allied Healthcare International Inc. (http://www.alliedhealthcare.com) is a leading provider of flexible healthcare staffing services in the United Kingdom. Allied operates a community-based network of approximately 100 branches with the capacity to provide carers (known as home health aides in the U.S.), nurses, and specialized medical personnel to locations covering approximately 90% of the U.K. population. Allied meets the needs of Private Patients, Community Care, Nursing Homes and Hospitals. The company also supplies medical-grade oxygen for use in respiratory therapy to the U.K. pharmacy market and Northern Ireland and oxygen concentrators to customers in Northern Ireland. Following the award of the new oxygen contracts, the Company now also provides unified oxygen services directly to customers in the South East of England.

FORWARD-LOOKING STATEMENTS

Certain statements contained in this news release may be forward-looking statements. These forward-looking statements are based on current expectations and projections about future events. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking statements include: Allied’s ability to continue to recruit and retain qualified flexible healthcare staff; ability to enter into contracts with hospitals and other healthcare facility customers on terms attractive to Allied; the general level of patient occupancy at hospital and healthcare facilities of Allied’s customers; demand for the services provided by Allied; the ability to successfully implement acquisition and integration strategies; dependence on the proper functioning of Allied’s information systems; the effect of existing or future government regulation of the healthcare industry, and ability to comply with these regulations; the impact of medical malpractice and other claims asserted against Allied; the effect of regulatory change that may apply to Allied and that may increase costs and reduce revenue and profitability; the ability to use net operating loss carry forwards to offset net income; and the impairment of goodwill, of which Allied has a substantial amount on the balance sheet, may have the effect of decreasing earnings or increasing losses. Other factors that could cause actual results to differ from those implied by the forward-looking statements in this press release include those described in Allied’s most recently filed SEC documents, such as its most recent annual report on Form 10-K, all quarterly reports on form 10-Q and any current reports on Form 8-K filed since the date of the last Form 10-K. Allied undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.




For further information:

Allied Healthcare Contact:
David Moffatt
Chief Financial Officer
(212) 750-0064
david@alliedhealthcare.com

Investor Contact:
Adam Holdsworth
The Investor Relations Group
(212) 825-3210
adamholdsworth@investorrelationsgroup.com

- FINANCIAL TABLE ATTACHED -

- more -




ALLIED HEALTHCARE INTERNATIONAL INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)


  Three Months Ended Nine Months Ended
  June 30,
2006
June 30,
2005
June 30,
2006
June 30,
2005
Total revenues $ 73,170
$ 89,483
$ 220,123
$ 266,861
Gross profit 22,176
26,215
67,438
77,625
Selling, general and administrative expenses 19,301
18,259
54,892
53,509
Operating income 2,875
7,956
12,546
24,116
Interest and other expense, net 945
1,307
2,821
3,250
Foreign exchange (income) loss (88
)
68
(62
)
79
Income before income taxes 2,018
6,581
9,787
20,787
Provision for income taxes 668
1,927
2,462
6,251
Net income $ 1,350
$ 4,654
$ 7,325
$ 14,536
Basic net income per share of common stock $ 0.03
$ 0.10
$ 0.16
$ 0.33
Diluted net income per share of common stock $ 0.03
$ 0.10
$ 0.16
$ 0.32
Weighted average number of common shares outstanding:  
 
 
 
Basic 44,957
44,830
44,921
44,629
Diluted 44,957
45,329
45,108
45,147



GRAPHIC 3 spacer.gif begin 644 spacer.gif K1TE&.#EA`0`!`(```````````"'Y!`$`````+``````!``$```("1`$`.S\_ ` end GRAPHIC 4 html_alliedlogo.jpg begin 644 html_alliedlogo.jpg M_]C_X``02D9)1@`!`0$!(`$@``#__@`V($EM86=E(&=E;F5R871E9"!B>2!' M3E4@1VAO```!!`(#`0```````````````0<("0(&`P4*!/_$`$@0 M``("`0($`P4&`P8"!PD!``$"`P0%!A$`!Q(A"!,Q%")!46$5<8&1L?`C,M$) M%B1"H<'A\1#8?7\S_7A>#@W7[K_7 M]D_EP<)L/K^9_KP;#Z_F?Z\+QB3M\#^6_P#3YC[^XX-U^Z_U_9/Y<'!VWV[_ M`/\`1^[Y_/M\_IMWXZ_)Y7&X>K)>REZM0J1`F2Q;L+#$NP+$`LP+ML.T<89S M\%X:CF+SAPNC%DH8_P`G,ZA*N/8XY=ZV/.S=$F1E3?9@VW^$C83L`2YC!#&& MFIM6:@U?>]NSV0>Y(NXKPA1%4J(S$^76K(`D:C5NW7(Q[\0_P!=.<#" M-*"R\=Q\8\US<&XC5\22@Z6E,FS59=68^XKI0]]UJX##2&N:HIIJU7#>[43; M<,55&/8QD\*U%^1GM^V[ZN]_E;OM[.5J\2>U5XB,519JVD\>^9E'6#?O&>E0 M5P>QBAZ?:;*;;L6;R%.P&Q!ZN&.S7.3F'FNI&S;XR!B2L&'A6CT@^@6PO7<. MP]WO8V(W.PWX;7;<=QP;#Y#\AQ6;GG,_K9J`>0MAFME1UQU5&TF*%+CU:$3M MMP.="*EA-&NWS?$Y\YRJJHCD9LQ$X>RF'5>HSFM_Y!*HV?E\JHYR?_9SO]N/ MKLYG,W&+6\KE++'?J:>];D)W)/JTIW[[G\]_CQ\R7;T;!H[EU6[C=;5A2!\O M^LW'P_X<8[#Y#\AP;#Y#\APQA;&Q.99!["<:0KD=WRRSE-NB[[]Q[U?ONJKO MU*NZ[JJJO&$KG*NZN=]_=??QYWW_`(_G^2<;1B]?:UPSA\?J;+Q['=8IKB/%91$OLG4^+N;U,@A_S*L4C=$X4^K5WD7;8[CN.-][?,_F1]/B0-_GOW MXJL5GCD21&:.2-@4=&*.CCOU*RD%3OZ$$;>@.W$B^7_/C(XR2MBM9,4CI-A6B_/;3W\F+C^KD&'C%@=X@1LLK$ M,F.F*]S1M2WAF(>32]3E:Y\]DB77(YQ'R$K(XNI=]#NF.5K)2(-R[(A6[]M? M9/G:NZL^GS)NGOOTIY29.P^OYG^O!L/K^9_KQ\&,RF/R]&OD<9;@O4;2"2O: MKN'BE0[]P=^H.I'3(C`2(^ZNH8$<=AQ87'D@E@!*B'%)BR1#/&DQRL,"0`K& MD"8!AN<,HBC5KQD&YS'L5KFJJ*B\*!'(J(J*BHNRHJ*BHN_E-OONBHJ?GPFP M^OYG^O!L/K^9_KPO!Q[;K]U_K^R?RXYX38?7\S_7@V'U_,_UX7@X-U^Z_P!? MV3^7!P@]/Q/ZG@X!Z?B?U/!QQP<+P<'!P<'!P<'";_7]_=P<'",=AO\`LGY? MK_OVWXC)S9YT_9SV--Z/LQO>`:+)9J$B1:)/8UL=("8VMKW$]C9TKD],9:9= MT.6A\WL5I9B5'0"(Z'$>V:TYH:;M+3971HK_F3=I"M7V]MV#7[_`$>Y M/;]EOS;JBNTDTCRRN\LLKM)))(Q>221V+/([.2SNQ)+,Q))))/<\9+V'KW/U M^7_#;T^`!^G'$2$!8D`*I9B3L`H_F+$]@J_$L0H]3VX9#6'B`Y?Z3>6I#JJYSE57*K MGKU*KGN\JY5\JKEW557WX:O,]0,)T[K/C&<9138S`99W33\6/TO3/4JF**/)9`K_XC;MQ>2CE2-UBK'H8,%<_ M!FLKK366=9FS&J<]?ZF9NB;*6UC!;N0(H98XPH[@*%Z5'\HX[H+V5ST3_P!K M455^GA=]DW3SO_)/;B$>9?I&=*:8YXN'8SE.:/$Y6LGF2-C51(5-NEX"S?66 M_0ONJ2*2,]?;I^;=+4[.IM/4NKVS4&$K%/YEGS&/1E[_`.9#9Z@?_,OUX^:/ M6>DIF"1:IT^[$$]*YFAOL/4_]H&WKZ?/Z;#BHUT\QF>3^([]V>3^([';IW9V M!9]QV/4>X['UW!Y2GL438=ANH(`^0&PV'TW(_P!^W;8GLK_P]O;\ME\_AOM^ M._GAEB_I,C;'ZOE8;*9Y#]&_U*RF"Q'*G_P+LJ?7ZW&UKM6X.JE; MKW%(W#U+,-M2/F#7DE7;ZGMWX^GJ/S._Q'?MN=O3?\/0;;_=M3Q4R.3Q[(V/ MR5^@8R.CV*[9J!=O3I6"1%`![]/H3W[<.5@^>'-#`,H@U/9R42@@5,2.^^_S[;K_`%!^GP[?#?MQ$;2OBJQ%@Q5]88.UC9"`KY3$-[=3 M)W`$DE)Q';B#?S=-=[`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`FP9L4K#QI<24)IH\F.8:N84)A/801&.5KV.1R*J+PL&N1[6N:J.:Y$< MUR+ONBHBHOCQY_#@X.#@XR^.W"#T_$_J>#@'I^)_4\'!P<+P<'!P<"KMP<,9 MSCYFC2%`X7$RDZBRE9C'(C#_`.%5'_AM=?UVL2CK6FG8A@9V]U!NX6N-6T]% MZ>NYNV1(\0$5&KU=+W;LVZUZZ`^J;CS9F4'IB21A\N*Z,SF;V:R-[,YBRUBY M;D>>S8E8*H"KN%!.R1001KT1IV2.-/AW/$)>B%QF@,YP"36N]QVEDK31JM4V?&8.18=0BC@]_1V]AZ8?:&_I,]%57[HG9&J M>7+]G.\HFZHJ(BN3;QQ\#.[LSNS2.Y9W=SU,SMNS.YWW=V8EF)_F)W/QW:SF M)S_FI(R]7!T&C>VY.WEM;D),>/@?J!\VP`S*&:**3;ADN;?B) M%0V]-\OYDFL=)@NZI0AX8&.W7%A@-UFF7555SEZE157J5=T_ M:@'I]W;TVV^7P.^YXRV'R'`>P[#[OA^_W M]_'IOO\`1$3Z(B(B<5)Y9F.59W,^#CC# M'T^/;]!O]!L=]R?38G8J.KA>HCU^F_J/7I^F^W?8D#I!W#$;#OW]NW':87/9G3MY, ME@LI=Q-Z(]K%&9X6[`#IE0;QS1D`!HY4EB8[D*"!QUW&)``[#X]N^VV_R/P_ M#CE%5/;^O;^'TXR(U[5\M)I\N_$Y7L-5Q&OZ_LDK%(5U+2&]21O=5'RE,#JKEN_FVJO5"" M"[01*QZ9":*3NLD,D;.CJ5]"C$?,]6W%.._ MT`^!W('KZ;_#N?0C<;]NH'U=7EKS:U)RYNQI6EER.G7D+7OV&VI'4C1[0LVZ6(W#!AU<)%\M3H=Y7;STKX3ROGQ^'T3Z^?/%CW+[S\7^/ MF@XMK4\^1T"N!$C9H$2.R&G&G;$C[D`&(N001)\YY3&_'&(TI'NMRO8%MS7* MGF39T1EA4N.\NG,E-$N0A)9O8I3_``TR-=>_2R;K[5&-A8@0G;KC!,]H+$-B M&*>"5)X9D62&6)U>.6-U#+(CJ2'5@=U()W'S._%/NB=;X'7V$BS6!L]:G:.[ M1F:-;^-L]RU:["K-Y;#U20=44\9#1,W<+-3D-S%\IHM#9>8]$KLVGK$C#:-S MU228MV9M^EVZI*0&^SM)"-@8QQ83R5\Q!:"SB:/9I.=\#MI*CPRQE$54IK>2 M]')0/>Y5VK[H&M>*Q1T6Y/#,KI\AJZVTI;.);T=S&#,J+6$9 MDB)(`9$5BB,S=.AZ[M5CMB`,CQ$8U[7M9+7@XQ##]=OAZ=_T_3C+BV#A?_?\ M/[\(/3\3^IX.`>GXG]3P<'!PO'%/+'!%)+*ZQQ1(\DDCL%2..-2TDCL2`$1` M68GT`WXY#Z?O]_GVXC;X@>8<.`PLNF*]R*O9R51[69M-(L<>/PB!WE$DC;"% MK80B0NR]-19'/9UW;_5'4.FTLP:^S:[]*(B!`1R8DV6&%&-).]HQA8Y[G/JHC6I[N`*!/Y8GEW5HTXCF M5#`@;^@7<[;D#8[;C?W?H/52`?B./G\R_*KO.,HNLPR22LNZOIYITLGS=L'6 MJ(&)&&]SNU%AQVBB0Q;J@(P!#1=VJJT<4PB M*(V4F:]PI%742&*KAXR-&=H\L3D=>HKQC7X0F]FBJ!Z;?#O\=AZ?/N!Z?/OU M?!0I/3\>PV';;X]O0[]A_F/^4'<[]@,O0?O]]SQL^B-)Y#7NM-+:+Q222WM5 M9[%X.N(ANT8R%J.">QOU+TK5KF:TS]2A%B9B0%;C2P84FRFPZ^$%\B9.E1X4 M2.Q%<0\F45@`!&B;JKRE(UC$^KG)Q7'7P)=I.@U==')+L+&9&@08H4W+)F3# MCCQHXFINKGG.08VM3=7.>B)NJ\3/Y#>`K6'.70<.OLMJR#0N.S`E?2]*QAK& M3NY6I'TK'EK(6U42IC;;]?L709K,\2&:O++4_*#76;T!JN)!EL/- M&5L51(U+(T+"M-1RE)I`DAJ7*X65"R@QL6AD"R(>/0YS"YF::\/6,Y*Z12*N M,=J35^FN6M*.S*4-'!PT'ISY<,IV]E:B$#<]2J1V&]@^M_+-IUB.D5A.PQ3R M-0-,DQM^H)DGS)*V$>\C1UD2"P2D?$AH)\H5C$6"..T5:"2V3WW;%;:%S$\H M>E>"Z&VMC@+Y4K4_1]N)%U1.EG82W6D;)(T994DU: M/+;+]21$,C%>!CPX\O>?.0U_>YA1Y.]C-)P82O2Q&/R=O$K8MYGVZ1[5J[2> M.XRUH:?E001SQJ3+URR3(`@VOEIX2N7.>\6_-#E!FK6ID MKR71B9*-"_E*RQ6?)HKDI5FFK"*:V$A+,A:0EU/[+/\`[/SI^'^)T9Z=MMX, MX=OF!W/;?;Z<.CR?`_\`>"^(T?\`V=B__3Z7]?P[;?=\N-EICI?I[::5\L%O M8XA23;/)M5;:!D,Z1#:21=5X1Z@D%`LWN7>9!&^CJT;#/UQT;&Z>VC#2&EV^ MC^C>EUUHOR"_1"^+33_);!Z@R^"T7J30\NOV#RIDF73[, MSTE.SD\?8Q*U&>6.Y3KTX[5*=+>VTM99()E0!Y>L],L/%#H;4?,3QP[AZ^)S>L[UJQ4AZXUFLR0Q-6CA=O)E,_185H"R\1?\ M=7*K7V@]<:.R&KN9&H.:B:HQ-ZKALEFJ=6G?QCXRY62SAHL?B_\`"=$\EZ&S M`]:"-[,DDLDU* MKK:!%J\4@REQ0SZ.-1OM!V;8@5LGPFQH--)JG.R*,\DJ.ZL$,$%E]!^7[_?I MPN_%GO)S^S:S6J=/T=12OF47#DS9--IRUOH/B:5GQ&H7*' M0.TAT,W&4G+<.D*)>I*M(OQA7?J_AW<^3BKWC%O3L1]/]C^>Q^X'UXWSE]RQ MUES.UM0T!I/$S7-27IYXGJS@U(\;'19AD;65DF"-0JX_H(M--LZ2#R(XWG*( M;4\3_9=Z57$0KG.:6HI,\U?>Q-BL)C$Q,-DKV$%:W));FKPN0"TUF&2=5WZ8 M-SLF=-M`]4=6(UA.PS'%FUU8?TLJPFS855"];TM(Z"`]@>.DF6,;F/.*.A$C M-()93@]\/<2&DW+3K+K;#M+'3_$WV%542?13+6PL:^EKUL$8PKJZ+)LY,9)D MT8R#)(#%0OI&%`Z:Z.DF.I-`\)7@UY4 M'#D];Y%\LZO+NWFJ^H/L[/Y MN]5RU>L]$VZ.4O);K&>FTDPKV5!:.>-)9(^M"T;%&''F\UVZ)KC6S2,L8.MM M7^\Q55W&H\F`-SL-R`=AN!ZG;<[\/KS-Z74VG&EN@K&XM78YETBFL8F9%BC` MDR?;Q8./EE?$9<8I0SS!GR9G:D=TS6C(HXQ4C(-B2.YOM&\>THT:Y:&LPNJQ M3.I5!;0<^/#%&2?974*NQHI?>D,015'%-Z5H6-XM)ZM MSFB:G)(O\"TH]QU>*3ID7WJLA)&?Y94 M.^X4JP)/;N`1OWVV)'O;_P`VP]>._P!-ZDS&DLU2S^#LFM?I2]2'L8IXW'3+ M7LQGW98)H]XYH3V93NA5T5A"='*CF/8]1E&YCQ%8JM>-[%:YCFN:J*U45$C@R7RKK3JUF#)?XXU[7DA$)VQDO*%2;MC6<<;6O M+%ZA1+80TC27"*D2;"]/_*K7::YTZEJPT:9G'L*>8@0@#S0H,%Q$))6&Y$.L M`[A9EFCW]W9NDSH"HDFA`(N4 M9N@D,DE5SYG6&MAJV8+E>&U5ECGK6(TFKS1,'CEAD4,DB,.Q5@=QMZ`@$#B\ M+E1UM75W3]D.ZDH3.,/2-5Y$A'-[]G'<-4J\A1J(U7?$1"(*:Y$V2RC2G]`P MGCH[Z(IRG&K./<4]M$%+A3X[EZ9`")MN\;T::/("1'QYL60P/)&(XWC;SCT_$_J>#@'^Y_4\'$I>%IQTNHLY1TYA?SQ1^(#(ZXU%G=/8FZK5[5DC4=^LYZ;$D3 ME5P%.92R_9="(0P6G0'VF1#%N8UD+31_M`_$3_=BM%RBTO>D3/W:L5_.SURO M5C*U@MY"/)U?P[;5FD-9-B4:7VD`-7`-,)))V]=RS$G8L6)[LQ/Y=C_,[ M,3L54<4]<[FL+LRSD>GM/+Z\VD`]U6#J:CA3 M'V^W6P@U2H?](%S4&B%F:%:?V:L/V>WJ'U]\]J MIVXY&5:JY9%D$2['TW^))V)[D-N2>_OQ.WSWWV&^VWR[_`=SOQ8U_9N\JO[U75)8,:SHODRZDU#7LUXW'4O>3'XQ;$ZE6!C-B,N"7!XKE;X;]A\3MOV M^[8[_/;Z?3<>@_P5:1QG*OPR8;4%]J\,VHJN7YBZBMAU;HK21R-41YE!ZQ1P MN.KQD+NHE,S`=3[<2MY-\&CYAK-665DP:T^"PI.837&V0/JH#P1Z='*OA'`M M)4>Q3=>E65Y47QOO-#D+TYC9YK_3VUJP;J+3:OEYY8*=6M#ZRL?'C42.<[PC MH]S,BVJ=?RJ.K,BJB;HK$^.3DWX@>UW;217+]>P&IQ4\9!'*8U`>.;HZE))]7TVTF M=&9;2JXNVM!L\N>&2QN1>Q$UU)!B\2T(J7(!5FB:&0;R(RR;@J)U8-E7+GFF M?ZAP,>U)N\GO];H1JRYQVTJ[:-4$!65$T0AU1)N+5@8[X-/ZL,9)-D=Y!-:U MG=/VU6R#3?->5+4#4[5.LQ;5O(-U M(W5D92K*VS*P(8;CLYW)_P#[P;Q&?_AV+_\`3Z6X<3PX*\RN9T$U45O2\]837&&IV M;>%%)Z&F`Y/#Q%&Y/VMN._UQ_P!XSR>__2F:_P#]M<\;WSMT3A]=>)3PRX_. MUTN8[#U>9>J33D"F*S;P$&!LXL2(X(DCAR+U;31]_,$/2P*%R-`UM+&_]HSR MAZ9$)3DMF4+OFS7Y,<[?#3KFT?-QM M"375//5XP))VT_F5PF,R-F&(LC.]))EN1`%>N6NL1;9]BHIUC0U.)ZT6>3*' M_#\#F9QF3;ND-:^.R#'O-)WR"2&.16E`%C'%.)6OZQ,>SH=U=*JJRM<:I<)Y M@;?+UCKB];S?XA,O72482*.MC9)HB26:4-V[2QHXV.-*"J.[@!D8K'H[I<\7 MBBY5<[>;F$P6FN57,/%>#'Q[6I[D0 MFKM//[,K+/"KJ/D\+W*?GIRAH9W`2L43\=CSXY4WO$-H?3F5Y8E()(C$1+(H83E7X)N8]"])=YP M^(7F%GZT:$5\%HG7FO,5#+*2=I+V8OY..\84'3M7JUJ[,VQ:WT@QNIKVIOHV MM4;+\>TVR[)32Z^*R'F`=5!5V#?#"UC(Y(LS'">H8&,)[GR?3@KYJ2YJCMXK M2RGN<)79)1Y+$YA(>=XOI+G672)U7!'`SR/K2&JTY^#R*@<0T*=BA5EL!$"] MSY:1(U78).GJ.]AM-++U"=3D[RSTKISQ1^)?5&)K5DMSU=`%4C$9^S[.K,=> MS6HHXU0$5GOWL;!;FC`\PB9>K^$4XKZ\9_B8YN5.>NI-(Z2UIJ#1^G-"6*&. MH5,%>..-W(I0K7;^3R$L*F2X\EBTT->&8R5HZT,2&N6>4\/?X;>8FA.5'BPY MS\I:NL[FH--:WR6+ATWJK/YB?,VK>K,%2VFP>2SMQY);]F);F0PU3(2S'VF; M&QP&1Y98`SF>)7P(08G_2%I75]'2%_,QTXM64\EC+.0@MV*<25H\OC_9Y MHC#I&@T^KT38RKR6KUGS5^98]BV118 MAT0F695*?$!6FTI^7D8Z; M+:7F`U")GN+89E<*%);W,WS28^%&OQ2*B+.BL^+8W;!?W(4>=7`">,US(HX[ MI"^$[F?GN;G(K1>K]3L+&HF^T,-F;JQ1PKD;>$R4E`9/HC`C$EVND$UGRE2, MVVG$:(@"BB;1^NL3RZY]Y_4^?QE7,X&'5G,2GE\9:PF(SZV:]S*YI*WE4,W! M/2$T632A*+/2DT,:2]$@1I%?T0\I^76!Y1\O],Y428UQ%?LA53AON>J7F>!Z?\I$N^LF3\_P`2CRRW-B8GKAS< MGIJG`W6!I17*GQ`QQ7/V0RIQ*[.\_.2^;Y29'34G+.E%S,RV M@%TY>UC7TQ@*"+G(]N`/0$GMZD=]@._P!?4`[C/8?+_;]_\!\AP;#]_O\`/Y_'B`.8YS=9P>KD M78ZQA:FL#51WUM;&KE-'"]Y.]-6.UJS)I2$(61-D*^20: MB2:>5D(ZAAZ2G!217U55$JW&B@(\R'GNC,:Z?8F,4QI5A*<25*,1Q#$?PLW1-`X6S78L*N2I,?XU.XG?JCE7<=6QEKS'SH"7`W]`'A(Y MT87F/H^/&T[H=Z0>7'UIV5;=:'<&]B)EZCO8Q\["2%5W\RG.DJ$Q)[OG78;= M]C\/0]_C\2=M_P#PD]OG\.'U\/O.K+8K.Q32M@Y+]5LU4C!Z?*#%&MPQ M]MI$ADE@E526L4WF0@GH"K30?567I#J31Y8Q2/JG.6IR6&-SD];CT\@FS6-8 MBHA#PGL%9PFN5$=,AA8YS1D)O*'DOYH)6A^9Q\9RF:5^F.431BLVE*(4YJ.D06BD^G5?3\3^IX..ETUGL9JG`XK46$L) M;Q>8I07Z4\1ZD>&P@D`W'^9"Q1Q\&4CX<'%_4.9%L(D6?!D"EPIL<$N)*`]" M`DQ9(VF`<)&JK7B,)["#>U51S'(J>%X^AH)1F$(P2,*$HV%$43T((@R-1S"# M>U5:]CVJCF/:JHYJHJ*J+QYV?&=R[U3H/GOJ^QJ.[/H00PQ-%'MUA(L#T''H[\6O)3&$1EL5HX@SNT6W<^SLWM#(#O+7]IA/\^W'G=U)IW*:2SE_3^:B$&1QTQCE M"$M!+$P#PVJTA`\RK9B*S0N=B4D`<"2*0+1+S.:6S-+=5[Z"J%+29">1D^.S M"O(5QJ^SE&*:*0Q%<\DJLG+(A'4CW&(,<>854]8S?YZ>>#EWM=(-2K+,:])E MA@>H5O.MZ^R.XLA]5?V)CS[/'["45Y2D+W5D3:LYW]%XCUQ"'C%O4?/X>FV_PW)VV'S^`[$D=CQ*G'W_`!/4/#99SV/U7F(. M0;Y&SI.?'IFJ`EC]HMK6LT(:)B&7@PT]Z1ZTT<%I8':293"*LKL\5G';\_Q_ M?[^8MQY-:?Y=ZF\`'V1S1UI/R_T?/S!RLEW4U6F;\U2U#JA'HP+6%6\7]KLA M(&8UWZ5)+%0.H/OH)BLG+[?/*R'D-GCDJ)I=EUO%EPPIM=E( M,0KYDVO)3!C5V4V\MXH3<5DNF.=7(/#5@DGE2,H40`$R2LJ-TF@^9 M&N.6&:_O#H+4^2TMF9:S49+6/>,-9]KF90S.#L0YB_=QK8[['R4F#FI4JZHV.QQFCF@ ME]I+!90`G2K@$#AP(O#?RZY5>0N@^8&G+V-J)S&YA:IU=A\5J6*U9/ ML5_(8[&9%?M&Y%!Y4EQ(Z=K&Q0PE*N/)LQ._#UU7*ID+HF%7N*Y8&GM1X^*U MO\BJ+.7E$,-_993=5%$/&I>!0[&0R(D*M<^TLVRC1JQ022R9(]GQV2"I>2O* MGU^GV1X7F\>BN@XP"ZR7**&WG9C`C9/;9GD-#C8\2GZ95]K*9`2NIWDN;ADR M1%IW1IAIDP72Z,RGO%>(3G5A=79C7N-YD:CAU=J&K#3S69>S%8DR-*LP-6O8 MK68):7LU$CIIHE:/V8;QQ!%?9NTY.Y[FUJKG?A+.C=>7\)S)UQF)JEC6%VZS MRRRY3W\A/E?X5CVVO*D0D:J:LBOY4*UU01Q&*PR+D%R-\-^$YX\W-5:?H\W< M-I[4-/%Z`T]8GKWZ>/JY&GC[T-&S/+[35&02SE$HV6D^/]MQ0:JD M<,%8QI'8KUJQDD7CTHM`]0_C%)#S#5)HK>FMPYM/PL.19/(N05!\X%C%AE%5 M:QQOJHUI;SW2#"F`F,L5:>/+D/:0Y$'Z8URRZII?8]`SO69@;S'[P6H=CI]' MRG,).01*,^HP,.M1:4^,@LFO+[)]G++)+CJM7RZ]0 M6!-"8W)Y5I%4$Q<:USJYJ\_N8%.;&:CYH:B?&6%*6,?AFJX&I M91^[)83"0U9IXCV`B,_E%2`X;=NJPZ[X;N1O+WG'S_YB:BTJF5Y<7-70>*SNJ-;4,;?KR4-6446MC]/X*6/&P8YWK0W;)RUMY*E:5EJ MBA&\T%B9T:]FDFKE6*NTYD:U?"+.]O[3',9P%N1YFL&ZK:7(BXQ9VXTA1B5% M=4A-#L9;(4Y@),JNKICQQ5D,],YG&:'ZYTHJG2B5S!I0V^2Y/4R5:!1_#2'+7JD]X/&O2D;/8FECB`4$%>]@/+J?PT>(7"\\HQ2BJ96..I!5AQV7BMXM'Z&6U8KHXC@OR+YRG[3H' MP[T=+^'GEY;Y18B]KGGIH7"81=2UX(J8PE27%U\CFM33VY'>>?/13M++1:M` MMV:9DCFNU:H(/IB^@>:TT1N0X#KC4UM->0W#BWE#-S.A;<2DR,&)QZ8H(T&/ M.62>_ELA1T.%X$<3U#7]IRDX]<-Y9]0:"$W*-,^8ZBJ.'D>,V.?XVV M]F-RR/A$:@-%BUL2S67*R::*!%20`D9.ZLAA.P]3-K(QOB/Y[XBIJ*C0YJ:O M2OJJQY;O0+6N6DL6HY9Z<]B!$B:2E-5]R*,Q"-4C;AE=V9R[EF M=CU.SDL[,Q+EV+L69G+ERYWZR2S,9'WXOMM>'GE19S.4Y5W>0F@L#RTKX9J& M.YIIK7"?WXCSBU%>+(2XH].9BF:U(?+GL7Y9)IE$MJI[+,8EH[UQIR/1VMM6 M:3BOQ92+3>H\MA(LE`4:"_#C;DM:"W$8F:(B:)%9BC.G6SA&$05`W&N6E&H6 MG<#'Y&7Y;)RRN?.MJ6(LDV2M;3V\5P9-G%A1,FC0S&KIKB=^+=58GUUJH#/0 MJ/&SK:CF+T3U1TLK<4E9UG$O-ZHEC=X_"69)R]B45Y">&7;PZZ%F,.`>14V# MB>JA9!2A+4W2QSD0W<&SN:UP<'!Q''B+'!QBJ2RS1PPHTDLLB1QQH"SR/(0B M*BCN@A1%V[IWHCC%5-U'&BB[DJ4945H(P#&?LP;EX=;1;2')M<-0*?!,9%T. MF$23;VSV.?$HJ0!!>OMI?2J;M"TC!1@];%ESC18K7L4_6VSOP9\O-4\L^0VF M\#J^]--E+MN_J"*E([R?8F/R_D34\.CL2Q6!$:PRDD)-:EC3IC544XE'&`J* MJJ%50%55'2JJO8*%V&P4#8`=MAV[<''T.81BL3!\/QK#X)C28F-TM?3ADR'= M1Y"0H[`N.3RJ-<9[7$[;?U8D<@QH@V-1/I]PS%:W!L2QO#:9TI]5B]+6T5>^ M=(?+F/B5D444+Y,@GS%,]@D<]=FL155HV#&C6(DL:R1NCJKJZ,CHP#*Z,I5D M<'^96!((^(/%2'B\\.=3(Y*S)BHDJY(P39/2UWR^F.Q5+R26=.6Y%3IZ()RP MILNYK&2LVWE22KQ;D?3]_O\`V^?;?AO.9>BXM;Z7MXT!4R,!]MQ$Y"_P[T*- MTP[D;^5;0O7E&X#%TD_R#AE.:/1E-8-.9(JL#79CB_?NL7>C6J685@?\_0J] M5;L.YCC8,2*Y&-L05YGJC!/WTNING>.:HX;,Q35[$6Z2 M1/&W=6!(/>I(!$F8%,L& MQUU'Z5CR$:]456XQZ6]V"QUP,CQ5X6*]FC8GIVZ\U2U6D:&Q5LQ/!/!-'V:. M6*0!T=0-BK`=@3OM[QHN>QXWD&09`E"]PC!*QPRA*Q5:\9&.1',>UR*U6O1' M(J*BINB\?.!S`:`95H'EY*:V82PQNR+)/BN3#$YL:VA,(GZB3LBLB7,-CF-L MH"NW8YS)(%+#.`SN)MMNYV]=SV&P]2=SZ>GKL0/EQ)>'Q#11>%^;P[IIF5KD M^L&U"=4')1BLE%\HF5-9<;Y'G^U^>C5ED,[0B$>:59FZ!&=CN/7;U[_+Z[[' M;Z'8^H[=^TI]/\I]/ZOY<\OYWG33]J:+6>4S.9BJ&U)I45HXO+ M'8;.L:A(P2X`46.93>8M\;6CF>C7(L?M,5ME]/'D>II+=H76$1/4"+V%.D4> MTB/VY0^C8)6=3E7!T/I-1L@GY[6Z:3X,2TL-/9])=1)J5[/C>-Y/D>*XW84\ M>7:C=!K2G-;0I3[$IX+HL:'(44T)')U_%RA\1*>Q6>O,]DQ+-':K>SR1-Y\?3*.@[J_$?C5Y;:OQ>E+7.OP M^8KF%KK1M.O0QFI4RM>*&\E2-1"]^I>K2R*9[(>Q9JR?:-/VEYIH88S+Y1:W M2/)CELTWVC9SUK4V&SNB*"[E72M8A4V:#3P^RT)$WFDD MDZDN5DDBD8^ M66*]'2.I5Y0ZYZCXW6U]'7W,$M+6U;*B-3VN.T%S6+$#0RKS$I40UG:+%>Y@G@"\`#.EH7QMT,1D.:6,UQRAT MYGN6?,_(C)6-!866"CC\)96K%CIE@ALU6I7$R%:G4ER3>30F;(U4OUFC9GC. MSZA\>.GQ:)S(ZOQ*[X:+)X[A*\K_`%)<`YD=H6Q!;])XM:S5_%+`N MB;`'B(N13T"V:BVTR@HW,2XN$4=LC+[);$Z^S"$&R@C<>4>L:QS8\3"7N#Q6>LYG44V:$FF\3F\=E#A["C#UK5QA#DJU>M;/MSV76*&2K,2PB,G6 MHZBW'3ZPY1X"?56I,UJO4E+1^)L9S!Z;P4.#P2QU[F3MX/'3$K3\V2.E30R] M,[]98RB6=YD0`<)V=K1J+95LZGE7_7`LPO#,`E35B<49,PD9V38HX#3,>N33 MCS_U;VN:-_I$1(3&A3#R3".:IV&R(MUDV+/CWY!P;:E':Z>A960)F=9QJ6>P MOLB0\:NI@/S&FE6$$XIY(D_XH&FCS1/A&IT=P>/25.=>K^8)Y>QW=!Z[TKI_ M2>I-"97*122SPX**T(\F+GL;T9+75D;]9J\].2M/CY$1WCF;J7J!XR-$:,UI MHC4O);D/@-`4-,'-UM045NP17-6XC4$,,<^)M6\=2!@CIVZT.1H3V&R!ANP( MR0I7\^*5IJW('!TFQM/56M+.,RN8U7D])8B"EBDM07[],]5.99#(SP13U^FQ M*LI00R3+#YBL&=DQ?A^PXGPV+U3K9L3G=19?+4,!CJ6-%B.[7P]EXYII9FF_ M@O8@A$T4;.B0O((>N5SL-\3F,U;(CU)DT=\CX_(R2-/)CN.EL:VRF7`<@F)4 M6!*@DNM@R[:,.9*KH1103.8X)@.CE,)^4AN=R400R2J(=A(RA^4AGV!M)`VV M+9'>9%CV0CK&VD]?6XB_(\DMZ&1$Q;O01W[J7)PRP0W;T-;'@3TH$LW)FC5XY?,8F&"+S) M"8Z\P?%!D]42\@,EIC"?W:S7(S`XNC4OSWQ?@RF6Q?L:BP(HXJYBQLD--$L5 MIG:5UL2QL[!!UZESBP5+`Z>Y48RNL!:#&:FHV;D=>*K-?:EGJ]=+%HQCJ>4H M&.[R/Y9=R-U)/#CZOY-Z*GN7<[5KE(16O(CL/)YG,WF[\LPX>9XT06%P=.Y5C7P:K"<`A5@ MLGITUD]7$GQXM765@\:LL><>QL6V0#S98F2`H09S"1WLCXU^3^:R&+ M3V4YOC'0UIL]]7Q#V9K]BU2K7TL30+(XA@ABF\N?H#`/#.XE$ M9V,=[<=:*Y:AIVA=J0V98JUP1&$6ZZ2,L-H0DEH18C03")MBA?;OMN$QG&J6 M8ZB"B,R>;6R6Q)$B>KH&/T-(^98SFB9,M+$U/6P"65C*:$2'E3'&>JLW^1RN MZF0U^M-;IB4\761<9B3665S+;5U<;3RMOS6O>9`L[_)*_#Q1[<\BU?!1(]U= MB>"U$#U%>8HG*\G%Q@3ON/D>_?\`W'<'O]_Q4$C@ZM]Q\/C]Q^[T_7\1L7NY M-\GKO,2\N3R*ST=(TI^FW;`\N7*31GJ./QK,/4]Q;MH&2JK[1NT[;*W6WA55 M=D1-]U]O=/\`7Z(GU7Q[\,Y@>"93J7E-7AV&U9;:[MB]`A,^4$8#5;ZB?.D* MG:B5\-CN[+E%5!B&FR=1',8[L^1O)VQK[)0YS,PR+I7'6XU$?01)G[J,I7'5 M0!L:R2",79%Z^H2"K&3(\C+Z$>3^A$T+I2O5F@C@R>0\NYD8XHU1*VT02ICH MU4`+%1@`3I``$SR=(`*GB./AYY7TK%JIEEH1T=,Z5>*#$488A'6L7X5+111[ M'9HZ!9)YR>HRSO&'9B)-YRJ-A^_^?Y]_N].+2.1319\"%)UDR&&YDNS#(J\( M"=NS@U;G=JUOD8N[FDL2#=75[UZ')!%/(Q"QK$!./HIY7N7?'-`<*97PNW8Y M+;H"1D^1J-S36TYC%:C(R/W)'J*_N%CUD95:O0IIAT65-.Y5'I^)_4\'`/3\ M3^IX.+'^)0<+PC#<;?O]_P"V_"\'!P*F_CB)W/SEXXD?7.)A+*PBBS\$:[E6 M7^%#E0%]$($<%O8>Z1',>QD;BN3F_P`E\;S#KRY7'%,?JZM6\NI:ZO+J9(1] MXZF3`!Z6'O)#>56EAW5'$L(Z4O`N5:]VM8IVHH[%:U#)7L02CJ2:&9#%)&X/ MJC*Q5CV]>QZAQ7]S/Y?SZ#SI@A623!9#>;#VG;75`+B@M43U`")T'A3&HJ1[.ODM3NP9X'/5\:4 M%4>PBN8[K"8@G4:YO!9C3>2FQ&=Q]G&9&L=I:UA>E@#OTR1LK&.:!U]])HF> M)U[!]NP<;!>CBL?J&A%)8CM>T31:@B:*1Y6BL1H'I*[>S MK$B"0G^.''$^]?Z[Q3^ZY)%>9 MP`PK^8]%V5NR+MOTK[[[;*K?JJ;??RFZIM[;TBZP<.HL M/C\3C:V,Q,D&(TIFM(P/-[9YLU'-2UYI;M1OB(:-G3VFKN5KXE,)%J"U7N2V_L^*%8D+TS8%%[:]((L&$-_-T@,Q/#&C M<'OV^8[_``&W^OJ/@!OML.,MQ^]^WW_+\>.W4Y%3V145?;[JNZ_S7?=/;_3B M.4+7'5BOC)"BYO:BB-@`JVQ7,@%`R)%A5]=$:(1H9&#D1(59"CPYPVMGQ&B< MZ-("0\AQG6N96O63YQ9+L; M`K_!"P&-C_##=+*RG!QPB[>$3QX]O'MMMLJ;;;;>/^O'$;6W5:'+D3H^;6S) M,L]E(F.<.`0H.'JS//?5 M&93)POAL!4KY/3]'3S058K:QU:U"\]R.>L#9[2MUBN8I.JND*`QQJ^Y/U1\_ MM0RW\M;R^FM-YJODLG0S=;&WHKC5<1F,;1JT*UNBWGM-TM%4BEFAE=U:;J9& M3J8%B^#@ZE^R>/;\/V?;S[?*FR>WCC-77[6-TM9Q,]MS2%*PST.&L-',\:72 M,21#+`?#D"9_B*Y,MV]-:PNZT@F M:.S'[9D+VP:G9CCG"1T((U6*!:PCF"J/,D9@#QLE'Q$:GK/%8N:;TQEKM'*W MLIA[MZO=\[$G)S227*E9XK"LT)25H(I&/G1QGL[$`A@^#@W_``3S[_EMM]/P MW3[;*J;<=(&O6L-9,//AY_=LERB1"RC&]%+64>!&K(D&3*;,B'9)E0A4U4^+ M*.TD@$J!&G"*V:SU"[OK+7^6UO#@H"[>TU?:6NEPS13:9C@6H$\RP M\;)8:NDED.I*DLD!1=@&?W'SX0D?`_O\=NX_Y[`[\'4NZKX\[[_FKDE1]K"JZ&5C%?'DJD=-F1:&=*K1]KMN M4)U>]SC(PK7X;G_J"W-F&S6EM*9ZAE[]7+#$Y*M;EIX_)U*-7'I9J]5AI2LL M=2.2:"5VC+-*$Z%=MVIU)J1=0_9;#!8;"/C:EBO*V'@>O]HR6;TUUK-M&=D\ MR%917AZ=EB@01_R=*IU.*Q>2S=^#&8BE8R60M/TP5*<;RV).^Q8(HVZ!O[\A M940!B\@4$B:G*SPXU,6*F>U_&M[*HPFKZ=$B2XVDZE3#)D)8NUVS&?>:LK>Q M1L=G-@+L!7(U/FV1OOLG[VR)[(B^5VV3?\NK=>'EP#'.83FBG.QV/.E75,TY MEO,KR"!!955#)=K'NY+9-^VM6<61ZU&2X5+!DEE-$X@(D4%8^6C6HY/\B;^L MI*^?U37L8W2JGS((#U5[V=Z=B%KAAYE?'/L5DME4EG`_PNX!E%C^B-&R9G(X MC2>GJ4=2O_"@2.K$L=;&XZ+8V+!50$2.O%U/LVPEE*+NTCC?JZ]9YG@JUH7D MDD>*O!7@3J9W7+1&PUPSH$$PSQL,H7Q[#++-C7-1L3 MK1P:>*?]GXG<*QX0JB]46*R9/Z7^F:(UT7+QRY87HC1I4X^%UA<3!@?D^6RP MC9:7!6;*V./IZD@5@B=7H:P17L"U7&D&ERU+**X>GL#0TUAZ&$QD?ETJ$(BC MZMC)*2Q>6:9NQ>:=V9Y"1MNW;8*`.\X.#B]Z!`A5<&'65L4$&OKHL>#!A1AM M#&B0X@F`C1@"8B-&$`1L$-C41K&-1J)LG$KFM:UK6M3I:U$1K43;9$1$1/X( MB)_#A!Z?B?U/!P#T_$_J>#C+X[<+P<'!P<'";=]_W^_IZ?';?C6-6Z6QFK\- M;PN4A#Q6$)KV`JF:E:5=X;==B"4EC?I[+[LJ!HG!5COM'!_P_P!._&OMJJMO M:R?37$*/8U5I$/!L($L;31I<22-PC@,-R*CF$&Y6K]4WW:J.1%3H]C7M5KD1 MS7(J.:J>'(NR+O\`P]O]^*R]5:6RNCLS/AW5L(8YZUF*.>&:-ATLDL4H>.12-^S`[[ M^[WVVL@U_H+&ZZPST;*I!D(5:3%Y+HZY:5C^;8[!6>M,0%LP[^\OO*.M`>(! MZBT[EM*96QA\U6-:Y!L=P>N"Q"QWCL5YNRRP2#N&79E.ZLJL"O%'W,IRY7.B M=^^PK!RK+3RYE.6BN7(\SZHY%<1M!X,HF'A26/&YI&(0;QD:K7QS-CF;MJ!N!&B^D0-5:'U5HBV*FI^WW'X M?+:J5KL$E:Y6@M5I>I9:]F&.Q7<$$$/%*KHWND@[CN/IVXC(TR[)U)U)NFR_ MO>53;[[_`(_[_1(%ZP;``QSE*^#)(J]5.88;`?AM]WP[=^W?Z]N_U7J'U^/P[]OI\?PWV^.W M%DFI?#WRUU`'E@Q#Z>N,&"V<%,U:,,5Z06H,6J.H[GH1(58]F)&VS(Y?PFY> M/J;!:OH6EV/1#EJ$U.1F`8+US5#9B&YZ22(#MML#QW1S%V^?95W\.3;[?P\_ MGOOXV\\5_P":Q[RHOS#B1YK M$7?I*_;S$GJ'[V/Z$_OMZ\+N/K^7?\O7\P.']M^&;FC`&\B#`Y#8[=,&9ABZ MP6`)'ML-?I`7WAN0=QV[^GR1^&[FQ))T-B,770[GS)-0XUD!`W'4())96W/N M[&-NW??CMX\?,WSM^\GC?[^?'U_Z[;\,Z;ERU\`;T[]'=1G/W:G4+$KJ0'=5 MV_\`4QXA8R(GGJ=WMF[HJ_*J*K&]0^OKMZ?O\O7X;;\'4/K^OZ=C^&_^AXDQ MC_"OKJPP^T,;#;TLD$L2`"-RZ>GO"MI:BZRZC MS63S[!5WJUU&*J$@@D^;')+;="1L4=ANNY+`\<=3$\*]-_LGS?[?V^OMYX7^ M+Z1ODD4:R2/V('9#TDJ=F[MQ(K0WALU?GWKW=4%-,8> M3H=Z\K+8S4\)(.T55/,BJF0,`LEN0,HW_P`.WN$3>TYHG2>DHECT[I_%XIE5 M5,]>LK6WZ?C+=E+VY"=SNS3;'?;TXVL#8>G;\M_4D]MO^1[;G<'HI?HU/JFZ MOV7Z?1/;WV]U5%]E1?K-W2C]'1BU(:/:ZL9(_+9(G#*F-X^DBKQ]"-5%<.;9 ME5EQ:`=LB(V.&B7;=I5.QW0FBZ,Y=:1T'6%?3N*B@G9"MC)V-K.4M]AOY]V1 M?,"ML-H(1%`-AM&.^^\'8=_@/NV^?<[GZ_'T';Y`)&V_IVW]/AMON>_R[G[O M7N3Q)7D]RADR#T]6:GKH<:%%G$XB=26O."&AO7$)`6HI!>"O(-[#A))%$0`= MP=+=+]+,K(L8;R M/1$L@KX6/8M35M'3P1M'%KJF&"#`B!39'/:",,8T5R_,1ZM4IB*KGN M>1ZJNP5PJ1U=:9^N?;)?XV`IR*0*L#J1]HV(B-_/F4]5)7[PQ;RD>9(O3 M*``$?/\`>_QW]?7Y['A$4!0.D*```!ML!MV`Z0!L.P&VP&PV'8$Y\7Q:4Z7X MWI%AE;AV-`3M16]^SLB#8R;=VQ6,29:3G,_:,9S&L"-7.;$B#CPQ+V8[.'/B MQ1Q1-$SVV17*J(CGO7;=SE_';V]D39OLG!P<'!PY'&5P@]/Q/ZG@X!Z?B?U/ M!P<'"\'!P<'!P<'!P<'!PA&XVXTC7&A<+KG%M1R<8BLQJYQV3BC1K>/G;9NN M(M_/#(5"SUFWCF0';H?I8;QP;?O]_P#+C47]!2Y33V&/Y#6Q+>FM8[XL^NFB M0L>0%^V[7-7YFO:J(\1AN88!6L,`@RC8]OF0;"LQWAS7>R_]MO=%3V7 MRGE$XK:UGH;.Z%R/L66A#P2DM2R==7-*Y'NP`21E`CG`[R59#YL9].M=G.I* MV_\`S_?RXM!R>(QN8I38[*4J]^E."):UF-98F_\`J`;O M;ADKS(0=CO'*BL0"/4`J>^Q/'%U#X]OP/].((F":.4H)`2QSA(HC`.-PC"(W MPX91O1KQD:[Y7,#<>N_;]_O_3UX\O'X?UM_X_TXXX78#T&W!P@(/;_8\<;G8[GT'SVV_P!? MQW_#Z<"JB)Y\(G^W_C@XY3V!/RXQ1)9Y$@ACDFEE<)%%$C222R,=DCB1%+N[ M'8*H!+$C;C>=(QWDS%^*2"A&GSC)42VG(`Z4K(_KNS(N[ M<3%T'RJT[H>-+*H,IG"#YF8MQ()(RP7JCHPCJ6K%V[-[]A@?>EZ20),:+TL]I&H%VQ MAULB6J.1O;#OY*]%1%3PJ]">[U5/94^7[N^G#62)JO4U%K*)'F4B>C@)$ M5TB;96BGRBM[K31D]:4@.B-NEK+,=XQ*.-`@"@`*H`55'2J@#8*HV`50```O M8``>@'&04>O?U_'?OZG<_P"G;\-MLN+D-+=*,-T@QH6-8?7]@3E8:SLI*H:U MNIR#:-TVQE=+>MZHW]5'"T4.*Q5'%CB8YR.5L6(&(-!B;MMMU.555SUV1-W* MJ;+OY39$1$^B)YX.#@X.')XRN#@X.#@X.$'I^)_4\'`/3\3^IX.#@X7@X.#@ MX.#@X.#@X.#@X.#@X.#A-@?V.#@X.#CH\YIO!:AKM7S6+I9*+I*J;,"/-%ON M"8;&PGA;N?>BD5AWV(X9/+^'72=L-+BLGE\.02WDEXLC`!_X8UL*DR*!V`,[ MGYL>#@X;;-](-,M0]RYGA-#>2FC5K;`\3T]JUB(FS&VT%T6S:--DV8V6C$V_ M9XQ21(TCR8+"+X3J5-G[=*?OMV=_KPR&>Y4?8LI1<_[2NYV+8ORFVZF'WJ`/NXU^'0AFE$?VJ%W'\WL!/S^'MH^7SX.#BK_--&]-ZK.'U%?CGIZ[U4 M4?IDN+XB=!3M8]O<-:$-LK5V_P")NU/V=N$K)C!'(1C&;-ZVIMU.7ZC^[E7Z MK]>'WH-A\#N.,MA_K MO]>_U_IMP<'$BMD;X1-DV;X3PGLG&P1-T1?KLG"\'!P<''/!P<'!P<'!P<'! 0P<'"#T_$_J>#@X.#@X__V3\_ ` end
-----END PRIVACY-ENHANCED MESSAGE-----